Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Copper Prices Hit Record Highs as Metals Rally Gains Momentum on Geopolitical Tensions
Thailand Moves to Regulate Gold Trading to Curb Baht Strength and Support Economic Growth
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Dollar Struggles as Policy Uncertainty Weighs on Markets Despite Official Support
U.S. and Taiwan Strengthen AI, Semiconductor, and Drone Cooperation at High-Level Economic Talks
Australia Wine Exports Fall in 2025 as Global Drinking Declines and China Demand Weakens
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations
Indonesian Stocks Plunge as MSCI Downgrade Risk Sparks Investor Exodus
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal
Australia Inflation Surprise Fuels Rate Hike Expectations Ahead of RBA Meeting
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges
UK Vehicle Production Falls Sharply in 2025 Amid Cyberattack, Tariffs, and Industry Restructuring 



